First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

No head-to-head clinical trials compare contemporary first-line therapies for metastatic renal cell carcinoma (mRCC). A network meta-analysis provides…

Read the full article here

Related Articles